revised informed consent policy: what’s new?. vha handbook 1004.01 informed consent for clinical...

43
Revised Informed Consent policy: What’s new?

Upload: kelley-bruce

Post on 26-Dec-2015

303 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Revised Informed Consent policy: What’s new?

Page 2: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

VHA HANDBOOK 1004.01

INFORMED CONSENT FOR

CLINICAL TREATMENTS AND

PROCEDURES

Page 3: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Major changes

Signature consent

iMedConsent

HIV testing

Home telehealth Who may obtain informed consent

Page 4: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Clarified procedures for:

obtaining consent for forensic or evidentiary exams

informed consent and disclosure of PHI related to 7332-protected info (i.e., HIV, alcohol/substance abuse

Informed consent when testing patients following an occupational exposure to bodily fluids

Page 5: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Who can obtain informed consent?

a. Any physician, dentist, or health care professional granted specific clinical privileges to perform the treatment or procedure.

b. Medical and dental residents, regardless of whether they have been granted specific clinical privileges.

c. Other health care professionals whose scope of practice agreement or other formal delineation of job responsibility specifically permits them to obtain informed consent, and who are appropriately trained and authorized to perform the procedure or provide the treatment for which consent is being obtained.

Page 6: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Who can obtain informed consent?

“other health care professional”

Page 7: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent

A properly executed VA authorized consent form is valid for a period of 60 calendar days from the date signed, instead of 30 days.

Page 8: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent

Exception – where there is a significant change in the patient’s condition that would reasonably be expected to alter the diagnosis or therapeutic decision

Page 9: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent - witnesses

Witness signatures are no longer required for signature consent except in limited circumstances.

Page 10: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent - witnesses

Exception - when the patient’s or surrogate’s signature is indicated on the VA authorized consent form by an “X.”

Exception - when an individual cannot physically document consent.

Page 11: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent – HIV testing

Signature consent is no longer required for Human Immunodeficiency Virus (HIV) testing.

Instead – specific oral informed consent

Page 12: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent – HIV testing

specific oral informed consent applies to tests for: 1. illicit drug use, 2. ETOH, 3. HIV, 4. Hepatitis B and C, 5. MRSA, 6. STDs, 7. inheritable genetic abnormalities

Page 13: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent – HIV testing

specific oral informed consent

Page 14: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Specific oral informed consent - HIV

Mandatory – includes written educational material which includes a description of:

• HIV disease, HIV testing• expected benefits/known risks associated with HIV

testing• reasonable alternatives to HIV testing,

consequences of choosing no HIV testing, availability of anonymous testing.

• meaning of a positive and a negative HIV test;• how HIV is transmitted; and• measures to be taken for prevention of HIV

transmission.

Page 15: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

iMedConsent ™

The iMedConsent™ software program must be used to document the informed consent process except in specific circumstances

Page 16: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

iMedConsent ™ - Exceptions

a. The patient declines to sign using the electronic signature pad;

b. There is a temporary system failure that prohibits proper use of the program;

c. The patient (or surrogate) is giving consent over the telephone or by fax; or

d. Use of the equipment that supports the iMedConsent software program would present introduce infection control issues

Page 17: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

iMedConsent ™ - Exceptions

Documenting informed consent

Form OF-522 is obsolete

Use - VA Form 10-431a or 10-431b

Page 18: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent – home telehealth

Signature consent is not required

Exception - unless the medical care delivered meets the usual requirements for signature consent.

Page 19: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent – when is it required?

Signature consent must be obtained for treatments and procedures that:

• Can be reasonably expected to produce significant pain or discomfort to the patient;

• Can be reasonably expected to produce pain or discomfort to the patient that is substantial enough to require sedation, anesthesia, or narcotic analgesia;

• Can be reasonably considered to have a significant risk of complication or morbidity;

Page 20: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Signature consent – when is it required?

Signature consent must be obtained for treatments and procedures that:

• Require injections of any substance into a joint space or body cavity (excluding the intravascular space); or

• Are listed in Appendix A of the informed consent policy.

Page 21: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Consent – home telehealth

The practitioner must ensure that the patient is informed about:

• a. The likely differences between receiving care delivered using telehealth technologies and face-to-face care, and

• b. That patients are free to choose among available comparable treatments or procedures that use telehealth and those that do not.

Page 22: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Collecting and releasing evidentiary materials / signature consent for forensic

examinations

If a patient is suspected of criminal wrongdoing or is the victim of a suspected crime presents for medical care at a VHA facility, the patient may undergo two types of treatments or procedures:

(a) treatments or procedures that are designed to address the patient’s specific medical and mental health needs, and

(b) a forensic examination to obtain all possible historical and physical evidence

Page 23: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Collecting and releasing evidentiary materials / signature consent for forensic

examinations

Follow the regular procedures for obtaining informed consent for treatments or

procedures

Page 24: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Collecting and releasing evidentiary materials / signature consent for forensic

examinations

A separate signature informed consent is required to perform a forensic exam

on a patient.

Page 25: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Collecting and releasing evidentiary materials / signature consent for forensic

examinations

A separate signature informed consent is required to perform a forensic exam

on a patient.

Page 26: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Collecting and releasing evidentiary materials / signature consent for forensic

examinations

Informed consent to an examination for evidentiary collection needs to be

obtained by a practitioner

trained in conducting forensic evidentiary examinations.

Page 27: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Collecting and releasing evidentiary materials / signature consent for forensic

examinations

The emergency exception does not apply to forensic examination.

Page 28: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Collecting and releasing evidentiary materials / signature consent for forensic

examinations

The patient has the right

to refuse an examination

Page 29: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Collecting and releasing evidentiary materials / signature consent for forensic

examinations

Disclosure

Page 30: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Informed consent requirements and procedures for disclosure of 7332-protected

information

Includes VA-generated records related to:

• drug abuse,

• alcoholism or alcohol abuse,

• infection with HIV infection, or

• sickle cell anemia

Page 31: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Informed consent requirements and procedures for disclosure of 7332-protected

information

Special written consent for disclosure:

VA Form 10-5345

Request For and Authorization to Release Medical Records

Page 32: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Informed consent requirements and procedures for disclosure of 7332-protected

information

Includes VA-generated records related to:

• drug abuse,

• alcoholism or alcohol abuse,

• infection with HIV infection, or

• sickle cell anemia

Page 33: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Obtaining consent for testing a source patient after an occupational exposure

When an employee is inadvertently exposed to a patient’s bodily fluids, tissues, or excretions (e.g., blood, urine, sweat, saliva, pus, fecal matter) there may be transmission of infectious pathogens (e.g., HIV, Hepatitis C, Hepatitis B, MRSA), contaminants (e.g., radiated isotopes), toxins, or other agents.

Page 34: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Obtaining consent for testing a source patient after an occupational exposure

The patient has the right to refuse testing

Page 35: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Obtaining consent for testing a source patient after an occupational exposure

Informed consent for source patient testing may only be obtained after the occupational exposure has occurred.

Page 36: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Obtaining consent for testing a source patient after an occupational exposure

Who can obtain informed consent?

• an employee who does not have a personal relationship with the exposed employee (e.g., friend, family member, former spouse) and,

• whenever possible, by an employee who is not professionally related to the employee or the patient.

Page 37: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Other issues

“Blanket consent”

Page 38: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Other issues

multiple or recurrent treatments or procedures

Page 39: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Other issues

“gurney consent”

Page 40: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Other issues

oral consent

Page 41: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Other issues

separate consent for anesthesia

Page 42: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

Other issues

consent for prescribing chronic narcotics

Page 43: Revised Informed Consent policy: What’s new?. VHA HANDBOOK 1004.01 INFORMED CONSENT FOR CLINICAL TREATMENTS AND PROCEDURES

?